Safety and clinical efficacy of immune checkpoint inhibitors in advanced gastric cancer in the real world
ConclusionsThe results of this paper show that the occurrence of irAEs is associated with patients ’ OS. irAEs occurrence can prolong patients’ OS. irAEs occurrence may serve as a surrogate marker for ICIs.
Source: Journal of Cancer Research and Clinical Oncology - Category: Cancer & Oncology Source Type: research
More News: Cancer | Cancer & Oncology | Gastric (Stomach) Cancer | Gastroenterology | Hypertension | Immunotherapy